Insider Transactions in Q3 2025 at Rapport Therapeutics, Inc. (RAPP)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 17
2025
|
Abraham Ceesay Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
35,585
-22.09%
|
$925,210
$26.67 P/Share
|
|
Sep 17
2025
|
Abraham Ceesay Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,835
-3.27%
|
$1,061,710
$26.59 P/Share
|
|
Sep 15
2025
|
David Bredt Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,500
-1.0%
|
$204,000
$24.27 P/Share
|
|
Sep 12
2025
|
Steven M Paul |
BUY
Open market or private purchase
|
Indirect |
41,666
+37.15%
|
$999,984
$24.74 P/Share
|
|
Sep 12
2025
|
Reid M Huber |
BUY
Open market or private purchase
|
Direct |
20,400
+50.0%
|
$489,600
$24.48 P/Share
|
|
Sep 11
2025
|
Wendy B. Young |
BUY
Open market or private purchase
|
Direct |
3,500
+26.92%
|
$77,000
$22.6 P/Share
|
|
Sep 08
2025
|
Cheryl Gault Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.83%
|
$190,000
$38.33 P/Share
|
|
Sep 08
2025
|
Cheryl Gault Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.75%
|
$5,000
$1.8 P/Share
|
|
Aug 15
2025
|
David Bredt Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,500
-0.98%
|
$127,500
$15.39 P/Share
|
|
Jul 15
2025
|
David Bredt Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,500
-1.92%
|
$119,000
$14.0 P/Share
|